Ghent University Academic Bibliography

Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia

Farzaneh Ghazavi (UGent) , Tim Lammens (UGent) , Nadine Van Roy (UGent) , Bruce Poppe (UGent) , Franki Speleman (UGent) , Yves Benoit (UGent) , Pieter Van Vlierberghe (UGent) and Barbara De Moerloose (UGent)

(2015) EXPERIMENTAL HEMATOLOGY. 43(8). p.640-653

Add to list

The long non-coding RNA H19 is regulated by LIN28B

Hetty Helsmoortel (UGent) , Barbara De Moerloose (UGent) , Tim Pieters (UGent) , Farzaneh Ghazavi (UGent) , S Bresolin, H Cavé, A Caye, ACH de Vries, C Flotho, V Labarque, et al.

(2015) HAEMATOLOGICA. 100(suppl. 2). p.5-6

Add to list

MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

Evelien Mets (UGent) , Joni Van der Meulen (UGent) , Gert Van Peer (UGent) , Michael Boice, Pieter Mestdagh (UGent) , Inge Van de Walle (UGent) , Tim Lammens (UGent) , Steven Goossens (UGent) , Barbara De Moerloose (UGent) , Yves Benoit (UGent) , et al.

(2015) LEUKEMIA. 29(4). p.798-806

Add to list

MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma

Anneleen Beckers (UGent) , Gert Van Peer (UGent) , Daniel R Carter, Moritz Gartlgruber, Carl Herrmann, Saurabh Agarwal, Hetty Helsmoortel (UGent) , Kristina Althoff, Jan J Molenaar, Belamy B Cheung, et al.

(2015) CANCER LETTERS. 366(1). p.123-132

Add to list

Journal Article
A1
open access

CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol

Farzaneh Ghazavi (UGent) , Emmanuelle Clappier, Tim Lammens (UGent) , Stefan Suciu, Aurélie Caye, Samira Zegrari, Marleen Bakkus, Nathalie Grardel, Yves Benoit (UGent) , Odile Minckes, et al.

(2015) HAEMATOLOGICA. 100(10). p.1311-1319

Add to list

Novel biological insights in T-cell acute lymphoblastic leukemia

Kaat Durinck (UGent) , Steven Goossens (UGent) , Sofie Peirs (UGent) , Annelynn Wallaert (UGent) , Wouter Van Loocke (UGent) , Filip Matthijssens (UGent) , Tim Pieters (UGent) , Gloria Milani (UGent) , Tim Lammens (UGent) , Pieter Rondou (UGent) , et al.

(2015) EXPERIMENTAL HEMATOLOGY. 43(8). p.625-639

Add to list

Childhood acute lymphoblastic leukemia : progress through collaboration

Ching-Hon Pui, Jun J Yang, Stephen P Hunger, Rob Pieters, Martin Schrappe, Andrea Biondi, Ajay Vora, Andre Baruchel, Lewis B Silverman, Kjeld Schmiegelow, et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(27). p.2938-2948

Add to list

Juvenile myelomonocytic leukaemia: the quest for more specific therapies

Hetty Helsmoortel (UGent) , Tim Lammens (UGent) , Nadine Van Roy (UGent) , Jan Philippé (UGent) , Pascale De Paepe, Yves Benoit (UGent) , Franki Speleman (UGent) , Pieter Van Vlierberghe (UGent) and Barbara De Moerloose (UGent)

(2014) BELGIAN JOURNAL OF HEMATOLOGY. 5(4). p.119-124

Add to list

ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

Sofie Peirs (UGent) , Filip Matthijssens (UGent) , Steven Goossens (UGent) , Inge Van de Walle (UGent) , Katia Ruggero, Charles E de Bock, Sandrine Degryse, Kirsten Canté-Barrett, Delphine Briot, Emmanuelle Clappier, et al.

(2014) BLOOD. 124(25). p.3738-3747

Add to list

Prognostic relevance of CD200/BTLA deletions in pediatric precursor-B cell acute lymphoblastic leukemia treated according to the EORTD-CLG 58951 protocol

Farzaneh Ghazavi (UGent) , Tim Lammens (UGent) , Emmanuelle Clappier, Stefan Suciu, Aurélie Caye, Samira Zegrari, Marleen Bakkus, Nathalie Grardel, Yves Benoit (UGent) , Yves Bertrand, et al.

(2014) BLOOD. 124(21).

Academic Bibliography

Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia

The long non-coding RNA H19 is regulated by LIN28B

MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma

CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol

Novel biological insights in T-cell acute lymphoblastic leukemia

Childhood acute lymphoblastic leukemia : progress through collaboration

Juvenile myelomonocytic leukaemia: the quest for more specific therapies

ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

Prognostic relevance of CD200/BTLA deletions in pediatric precursor-B cell acute lymphoblastic leukemia treated according to the EORTD-CLG 58951 protocol

Contents

Support

Contact